MomentumOptions.com Mid-Market for 12/15/2017
Pfizer (PFE) Gets Good News
2:55pm (EST)
Pfizer (PFE) announced the FDA has approved Remicade for as a treatment for patients with rheumatoid arthritis, Crohn’s disease, pediatric Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Obviously, this has been good news for our current position in PFE.
The market is hitting fresh all-time highs ahead of the weekend so there’s not much to add to it. As I head to press, the Dow is jumping 160 points to 24,669 while the S&P 500 is soaring 25 points to 2,667. The Nasdaq is surging 81 points to 6,938 and the Russell 2000 is zooming 27 points to 1,534.
The action has been bullish for a number of our current trades so let’s go check the tape. Have a great and safe weekend and I will be back with a full update Monday morning.
Momentum Options Play List
Closed Momentum Options Trades for 2017: 54-23 (70%). All trades are dated and time stamped for verification. New subscribers can look at the past history to see how the trades have played out or to research our Track Records.
Do not risk more than 5% of your trading account on any one trade but do try to take all of the trades. Please remember, all “Exit Targets” and “Stop Targets” are targets. You should not have any “Hard Stops” entered to close any trades or “Exit Orders” in your brokerage account unless I list one. I will send out a “Profit Alert” or “New Trade” if I want you to close a position or if a new trade comes out. Otherwise, follow instructions at all times in the 8am and 12pm–2pm (EST) updates. Also, I will usually give you a heads-up if I think I’m going to send a Trade Alert outside of these time frames.
Pfizer (PFE, $37.08, up $0.62)
PFE January 37 calls (PFE180119C00037000, $0.60, up $0.24)
Entry Price: $0.43 (12/14/2017)
Exit Target: $0.90
Return: 43%
Stop Target: None
Action: Fresh resistance at $37-$37.25. Support is at $36.75-$37.50.
Spider Gold Shares (GLD, $119.20, up $0.27)
GLD January 117 puts (GLD180117P00117000, $0.55, down $0.05)
Entry Price: $0.95 (12/11/2017)
Exit Target: $1.90
Return: -42%
Stop Target: None
Action: Resistance is at $119.25-$119.50. Support is at $119-$118.75.
Intel (INTC, $44.69, up $1.43)
INTC January 45 calls (INTC180119C00045000, $0.95, up $0.52)
Entry Price: $0.53 (12/11/2017)
Exit Target: $1.10
Return: 44%
Stop Target: None
Action: Fresh resistance is at $44.75-$45. Rising support is at $44.25-$44.
Bank of America (BAC, $29.09, up $0.36)
BAC January 30 calls (BAC180119C00030000, $0.45, up $0.10)
Entry Price: $0.50 (12/8/2017)
Exit Target: $1.00
Return: -10%
Stop Target: None
Action: Resistance is at $29-$29.25. Support is at $28.75-$28.50.
Viavi Systems (VIAV, $8.73, up $0.08)
VIAV January 9 calls (VIAV180119C00009000, $0.25, flat)
Entry Price: $0.65 (11/29/2017)
Exit Target: $1.30
Return: -42%
Stop Target: None
Action: Resistance is at $8.75-$9. Support is at $8.50.
Twitter (TWTR, $22.41, down $0.17)
TWTR January 24 calls (TWTR180119C00024000, $0.60, flat)
Entry Price: $0.70 (11/22/2017)
Exit Target: $1-$1.40 (Limit Order on half @ $1)
Return: -14%
Stop Target: 35 cents (Stop Limit)
Action: Support is at $22.25-$22. Resistance is at $22.75-$23.